26-040 Crovalimab NUB Anfrage DGHO_Stand 2025-09-03 final.pdf
NUB-Anfragen 2026
26-040 Crovalimab NUB Anfrage DGHO_Stand 2025-09-03 final.pdf
Dabrafenib.nub
26-041 Dabrafenib NUB Anfrage DGHO_Stand 2025-09-08 final.pdf
Dacomitinib.nub
26-042 Dacomitinib NUB Anfrage DGHO_Stand 2025-09-08_final.pdf
Danicopan.nub
26-043 Danicopan NUB Anfrage DGHO_Stand 2025-09-08 final.pdf
Decitabin-Cedazuridin_oral.nub
26-046 Decitabin-Cedaruzidin NUB Anfrage DGHO_Stand 2025-09-08 final.pdf
Denileukin_Diftitox.nub
26-047 Denileukin Diftitox NUB-Anfrage DGHO_Stand 2025-09-03 final.pdf
Efbemalenograstim_alfa.nub
26-049 Efbemalenograstim alfa NUB-Anfrage DGHO_Stand 2025-09-10 final.pdf
Elacestrant.nub
26-050 Elacestrant NUB-Anfrage DGHO_Stand 2025-09-10 final.pdf
Elranatamab.nub
26-051 Elranatamab NUB-Anfrage DGHO_Stand 2025-09-10 final.pdf
Emicizumab.nub
26-052 Emicizumab NUB-Anfrage DGHO_Stand 2025-09-10 final.pdf
Radioligandentherapie_mit_Lutetium-177-Vipivotidtetraxetan-PSMA-Liganden_bei_Prostatakarzinom.nub